These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2. Mize GJ; Wang W; Takayama TK Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807 [TBL] [Abstract][Full Text] [Related]
9. Conformational and biochemical analysis of the cyclic peptides which modulate serine protease activity. Pakkala M; Jylhäsalmi A; Wu P; Leinonen J; Stenman UH; Santa H; Vepsäläinen J; Peräkylä M; Närvänen A J Pept Sci; 2004 Jul; 10(7):439-47. PubMed ID: 15298179 [TBL] [Abstract][Full Text] [Related]
10. A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity. Guo S; Skala W; Magdolen V; Briza P; Biniossek ML; Schilling O; Kellermann J; Brandstetter H; Goettig P J Biol Chem; 2016 Jan; 291(2):593-604. PubMed ID: 26582203 [TBL] [Abstract][Full Text] [Related]
11. TMTP1, a novel tumor-homing peptide specifically targeting metastasis. Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541 [TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma. Luo LY; Shan SJ; Elliott MB; Soosaipillai A; Diamandis EP Clin Cancer Res; 2006 Feb; 12(3 Pt 1):742-50. PubMed ID: 16467084 [TBL] [Abstract][Full Text] [Related]
13. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity. Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031 [TBL] [Abstract][Full Text] [Related]
15. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides. Makovitzki A; Fink A; Shai Y Cancer Res; 2009 Apr; 69(8):3458-63. PubMed ID: 19351852 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6). Fernández IS; Ständker L; Mägert HJ; Forssmann WG; Giménez-Gallego G; Romero A J Mol Biol; 2008 Apr; 377(5):1488-97. PubMed ID: 18329042 [TBL] [Abstract][Full Text] [Related]
17. Inhibition profiles of human tissue kallikreins by serine protease inhibitors. Luo LY; Jiang W Biol Chem; 2006 Jun; 387(6):813-6. PubMed ID: 16800745 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of marinostatin, a serine protease inhibitor isolated from a marine organism. Taichi M; Yamazaki T; Kawahara K; Motooka D; Nakamura S; Harada S; Teshima T; Ohkubo T; Kobayashi Y; Nishiuchi Y J Pept Sci; 2010 Jul; 16(7):329-36. PubMed ID: 20552565 [TBL] [Abstract][Full Text] [Related]
19. 4-Heterocyclohexanone-based inhibitors of the serine protease plasmin. Sanders TC; Seto CT J Med Chem; 1999 Jul; 42(15):2969-76. PubMed ID: 10425106 [TBL] [Abstract][Full Text] [Related]
20. Human tissue kallikreins: the cancer biomarker family. Paliouras M; Borgono C; Diamandis EP Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]